Trial intelligence / Profile preview

Effect of fluvastatin on erectile function in patients with cardiovascular risk factors

2006-000284-28Phase 3Active

Sponsor
Saarland University Medical Center
Start
Mar 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of fluvastatin in erectile dysfunction (ED), sponsored by Saarland University Medical Center. Primary endpoint: Penile blood flow. Started Mar 2006; status: active.

02

Drugs

fluvastatin
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on 2006-000284-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-000284-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call